Alexza Pharma (ALXA) Posts Q4 GAAP EPS of $0.42
Tweet
Share
E-mailGet Alerts ALXA Hot Sheet
Price: $0.92 --0%
Financial Fact:
Loss from operations: -9.98M
Today's EPS Names:
HFBL, PBHC, PBNK, More
Financial Fact:
Loss from operations: -9.98M
Today's EPS Names:
HFBL, PBHC, PBNK, More
Join SI Premium – FREE
Alexza Pharmaceuticals Inc. (NASDAQ: ALXA) reported Q4 GAAP EPS of $0.42, which may not compare to the analyst estimate of $0.09. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $20.88 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- inTEST Corp (INTT) reported Q2 Revenue ; Offers Guidance
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Pinnacle Bank (PBNK) Tops Q2 EPS by 25c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
